



1. Departamento de Clínica e Odontologia Preventiva, Universidade Federal
de Pernambuco, Recife, PE, Brazil
2. Oral Medicine unit, Division of Maxillofacial Diagnostics, Surgical and
Medical Sciences, Eastman Dental Institute for Oral Health Care Sciences,
University of London, UK
Email: jleao@ufpe.br
Received for publication on June 12, 2007
Accepted for publication on August 27, 2007
ULCERATIVE LESIONS OF THE MOUTH: AN UPDATE
FOR THE GENERAL MEDICAL PRACTITIONER
Jair Carneiro Leão1, Valder Barbosa Gomes1, Stephen Porter2
Leão JC, Gomes VB, Porter S. Ulcerative lesions of the mouth: an update for the general medical practitioner. Clinics.
2007;62(6):769-80.
Oral ulceration is a common complaint of patients attending out-patient clinics. Because of the diversity in causes of oral ulceration,
patients presenting with oral mucosal disease can be challenging to diagnose and manage. Patients with signs or symptoms of oral
ulcers are sometimes referred to gastroenterology clinics; however, in most instances the ulcers do not result from gastrointestinal
disease. The aim of the present article is to review aspects of the etiology, diagnosis and management of common ulcerative
disorders of the oral mucosa. A search in the National Library of Medicine computerized bibliographic database MEDLINE was
performed. Selection of publications, extraction of data, and validity assessment were then performed by the authors. Based upon
the searched literature, it is concluded that there are several systemic disorders that can present with similar clinical signs and
symptoms, and knowledge of each disease is necessary for the clinician to provide proper management.
KEYWORDS Oral Ulceration. Oral Medicine. Oral Lesions. Recurrent Aphthous Stomatitis. Recurrent Oral Ulceration.
INTRODUCTION
Oral ulcers are one of the most common complaints of
the oral mucosa. The term ulcer is used where there is dam-
age to both the epithelium and lamina propria. Several pre-
disposing factors have been suggested and oral ulcers can
be a feature of various systemic disorders including inflam-
matory bowel disease. Oral ulcers are determined by the
underlying systemic condition such as the nature, site, du-
ration and frequency. In addition, histopathological exami-
nation usually produces a definitive diagnosis for the ma-
jority of conditions described in this paper. The aim of this
review is to provide a focus on ulcerative disorders, either
of general clinical significance, or relevant to gastroen-
terology.
Oral ulcers of traumatic (physical and chemical)
etiology
The majority of cases of ulcers of the oral mucosa are
due to physical trauma. However, chemical trauma must
also be considered. Salicylic acid (aspirin) and its deriva-
tives are extensively used for the treatment of systemic and
local diseases. However, injudicious use of these com-
pounds may cause systemic and oral complications, such
as mucosal burns and oral ulcers.1 In addition, ulcers may
arise (e.g. on the palate)2 with the use of powdered cocaine
or through the smoking crack cocaine. The effects of co-
caine in the oral cavity vary depending on the form used
and the route of administration. Rarely, snorting cocaine
may cause necrosis, possibly associated with ischemia, of
the floor of the nose; and eventually causing ulcers of the
hard palate as well as oronasal fistula formation.3
Oral ulcers can be caused by local radiotherapy and
some cytotoxic chemotherapy regimes (mucositis) (Fig.1).
The mucosistis manifests as multiple areas of painful mu-
cosal erythema, ulcers and sloughing.4 The precise etiology
of mucositis remains unclear, although most likely reflects
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a loss of basal cell proliferation5 rather than a reaction to
changes in the local oral microflora (e.g. increases in Gram-
negative bacteria, particularly Enterobacteriaceae).6 This
mucositis, akin to that of the bowel, is difficult to manage
specifically. Benzydamine hydrochloride mouth rinse or
spray may provide symptomatic relief, but effective anal-
gesia often requires opioids. The clinical features of oral
mucositis do not significantly improve with topical
chlorhexidine gluconate, although this compound is com-
monly used in clinical practice. Novel regimes for the treat-
ment of mucositis include granulocyte-macrophage colony-
stimulating factor (GM-CSF) and protegrins.7, 8
Necrotizing sialometaplasia
Necrotizing sialometaplasia is an uncommon disorder
that typically gives rise to large areas of deep ulcers on one
side of the hard and/or soft palate.9 This condition is con-
sidered to be associated with an ischemic event, and is as-
sociated with clinical factors such as smoking, alcohol use,
denture wearing, recent surgery, systemic disease, and it
can also be a feature of bulimia nervosa.10 It has been sug-
gested that the local traumas mentioned above cause
ischemia with resultant tissue necrosis. The clinical features
may mimic those of squamous cell carcinoma (SCC), and
histopathologically, the profound epithelial hyperplasia,
together with the salivary gland squamous metaplasia seen
with necrotizing sialometaplasia, can be confused with neo-
plasia.
Viral diseases
Herpes simplex virus 1
The most common viral precipitant of ulcers is herpes
simplex virus type 1 (HSV 1). Affected individuals may
have widespread, small, superficial ulcers of the oral mu-
cosa (Fig. 2). The gingiva are often swollen and ulcerated,
giving rise to features akin to acute necrotizing ulcerative
gingivitis (ANUG). While previously regarded as a disease
of childhood, primary HSV-1 infection often arises in the
second or third decade of life.11 Severe and/or recurrent
HSV-1 infection, sometimes presenting atypically, may be
suggestive of underlying immunodeficiency, in particular
lymphoproliferative disease or HIV disease.12
About 5% of patients who have a primary HSV-1 infec-
tion will develop recurrent episodes of herpes labialis (cold
sores), as illustrated in Figure 3. This comprises episodes of
paresthesia, erythema, vesiculation, pustulization, and ulcers
at the mucocutaneous junctions of the lips and/or nose.13-15
Precipitants of herpes labialis include concurrent illness,
UV light exposure, and pregnancy. Effective therapy en-
tails 5% aciclovir16 or 1% penciclovir.17 Herpes labialis may
itself be a precipitant of erythema multiforme.18
Figure 1 - Chemotherapy induced oral mucositis
Figure 2 - Primary infection of HSV-1 affecting the gingival, tongue and skin
Figure 3 - Recurrent herpes labialis vesicule stage on the upper lip
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This therapy typically provides symptomatic relief, al-
though systemic aciclovir and other anti-virals should be
considered when disease is severe, recurrent, or atypical.13
Aciclovir resistance may arise in immunosuppressed pa-
tients receiving repeated treatments, hence the need for
famciclovir, valciclovir or foscarnet.14 Interestingly,
foscarnet may itself give rise to oral ulcers,15 and while
aciclovir may be effective and useful in the treatment of
erythema multiforme, it can also give rise to this mucosal
disorder.
Herpes simplex virus 2, Epstein-Barr virus and
Cytomegalovirus
Although uncommon, HSV-2 can give rise to oral ul-
cers similar to that of mild primary HSV-1 infection. This
oral ulcer arises as a consequence of orogenital transmis-
sion of the causative virus.
Ulcers caused by Epstein–Barr virus (EBV) are rare, but
may be a feature of infectious mononucleosis. The ulcers
comprise a few small superficial ulcers of the oral mucosa.
EBV is more typically associated with the ulcers of some
non-Hodgkin’s lymphomas19 or white patches termed oral
hairy leukoplakia (OHL) that may arise in cases of immu-
nodeficiency (e.g. HIV, or with corticosteroid or other sys-
temic immunosuppressant therapy, etc.). It is also impor-
tant to remember that OHL has been observed in patients
with inflammatory bowel disease receiving immunosup-
pressive regimes.20
Cytomegalovirus (CMV) may give rise to large, chronic
ulcers of the oral mucosa or gingiva.21 These CMV-related
ulcers occur exclusively under conditions of significant
immunodeficiency, notably severe HIV disease. The diag-
nosis of such ulcers is difficult and is often only confirmed
by resolution of ulcers with ganciclovir therapy.22
Human herpesvirus 8 (Kaposi’s sarcoma herpes virus)
Human herpesvirus 8 (HHV-8) is an oncogenic virus,
which causes Kaposi’s sarcoma (KS). It is theorized that
this virus, when infecting circulating KS cell-progenitors,
predisposes a patient to KS development in the setting of
exposure to Th1 inflammatory cytokines. Lytic replication
caused by the virus can further promote tissue inflamma-
tion, thereby providing a proangiogenic stimulus that,
among other things, increases generation of matrix
metalloproteinases. In this multifactorial model of infec-
tion, hypoxia and injury can lead to the clinical expression
of KS. Commonly arising within the mouth of patients with
severe HIV disease or as a feature of profound iatrogenic
immunosuppression (e.g. in patients with inflammatory
bowel disease). Oral KS typically affects the palate or
gingiva and manifests as red, blue or purple macules,
papules, nodules or ulcers (Fig. 4).23 Oral KS may also oc-
casionally be non-pigmented, and hence may mimic SCC.24
Kaposi’s sarcoma of the anterior gingiva may be un-
sightly, and in rare instances, gingival lesions will cause
the destruction of underlying periodontal tissues, leading
to tooth loss and sequestration of bone.
Oral KS in HIV may be reduced or resolved with highly
active antiretroviral therapy (HAART); although some oral
lesions have been reported to resolve (probably transiently)
with local radiotherapy, local injection of cytotoxics, or
sclerosants.25 27
Human immunodeficiency virus
The oral consequences of HIV have been reviewed in de-
tail elsewhere.28,29 Infection with HIV gives rise to a wide spec-
trum of oral ulcerative lesions. The majority of these are de-
tailed in other sections of the review. A minority of patients
with severe HIV disease can develop deep, necrotic ulcers of
unknown etiology. These ulcers are painful, can cause pro-
found dysphagia and/or dysarthria, and can arise on any oral
mucosal surface, although the buccal and pharyngeal mucosae
are the more commonly affected sites. The precise etiology
of these HIV-related ulcers is unknown.30 HHV-8 DNA has
been detected within such ulcers, although it is unclear
whether the virus is causative or merely a passenger.31 Of note,
such ulcers typically resolve with systemic thalidomide (e.g.
200 mg daily), perhaps reflecting an antitumor necrosis fac-
tor (TNF)-á effect, which supports a viral etiology.32 Small
numbers of patients with HIV disease may have ulcers simi-
lar to those of recurrent aphthous stomatitis (RAS) (Fig. 5);
to date, the cause of RAS has not been established. This limi-
tation continues to compromise the clinician’s ability to pro-
vide effective therapy. Whether the frequency of RAS is truly
increased in HIV also remains unclear.33
Figure 4 - HIV associated Kaposi´s sarcoma
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Vincent’s disease manifests as painful ulcers of the
gingival margins, particularly the interdental areas. The ul-
cers may be localized or generalized and, when severe, they
will give rise to cervical lymphadenopathy and, very rarely,
to pyrexia and malaise. There is often oral malodor asso-
ciated with Vincent’s disease. Long-standing or recurrent
disease may lead to destruction and loss of interdental pa-
pillae.
An ANUG-like disease termed cancrum oris (noma)
(Figs. 7 and 8) can arise in profoundly malnourished chil-
dren and adults. Unlike the ANUG in immunocompetent
individuals, the ulcers of cancrum oris spread to the adja-
cent soft tissues, leading to necrosis of the lips and/or
cheeks. Cancrum oris has most commonly been reported
in children in Central Africa, where malnourishment arises
from poverty that results from political and economical
unrest.35
An ANUG-like disorder that spreads to the underlying
bone and adjacent soft tissues – termed necrotizing stoma-
titis – has been reported in a small number of patients with
severe HIV disease. Occasionally, this disorder may be the
first, and/or only clinical manifestation of HIV disease.36
Bacterial infection
Acute necrotizing ulcerative gingivitis
Acute necrotizing ulcerative gingivitis (Vincent’s dis-
ease, trench mouth, acute ulcerative gingivitis) is a non-
specific ulcerative disorder that is almost always localized
to the gingivae (Fig. 6).34 Associated contributing factors
include poorly controlled diabetes mellitus, tobacco smok-
ing, immunodeficiency (notably severe HIV disease), and
possibly psychological stress. This condition is also asso-
ciated with poor oral hygiene. Measles and malnutrition
have also been implicated as predisposing factors to Acute
Necrotizing Ulcerative Gingivitis (ANUG), common oral
diseases prevalent among children ages 3-6 years living in
rural communities.
Figure 5 - Oral ulceration in HIV infected patient
Figure 6 - Acute necrotizing ulcerative gingivitis also affecting the hard
palate Figure 8 - Cutaneous necrosis secondary to cancrum oris
Figure 7 - Oral ulceration, bone exposure and tooth mobility/loss in cancrum
oris
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Ulcers of ANUG typically resolve with the removal of
deposits of plaque and calculus and the topical application
of chlorhexidine gluconate mouth rinse (0.2%) or gel (1%).
Systemic antimicrobials (e.g. metronidazole or
phenoxymethyl penicillin) may be required when the gin-
givitis is profound and/or there is systemic upset. Cancrum
oris also requires tissue debridement and correction of the
underlying malnourishment; however, prognosis for the af-
fected children is often poor.37 Post-healing fibrosis and
scarring represent a significant complication of cancrum
oris.
Treponema pallidum
The frequency of oral ulcers due to infective syphilis
is likely to increase as a consequence of the rising number
of subjects affected with Treponema pallidum; this may re-
flect changes in sexual attitudes and behavior, changing
trends in HIV disease, and increased foreign travel.38 Oral
ulcers can arise in primary, secondary or tertiary disease.
In primary disease, a chancre can develop on the oral mu-
cosa as a consequence of direct contact with an infective
lesion. Ulcers of a primary infection typically arise on the
upper (in females) or lower lip (in males) and manifest as
a superficial to deep isolated ulcer that sometimes has a
rolled edge. Occasionally, there can be isolated ulcers of
the gingiva.39 The oral chancre typically resolves with an-
timicrobial therapy.40 Secondary syphilis can give rise to
multiple areas of superficial papules and ulcers, some of
the latter being serpiginous, and are thus termed snail-track
ulcers. Tertiary disease may produce ulcers as a conse-
quence of gumma formation, with the ulcers manifesting
as isolated areas of chronic ulceration, sometimes with the
destruction of the underlying soft and/or hard tissues (e.g.
palate or tongue).
Mycobacterial infection
Primary oral infection of Mycobacterium tuberculosis
is rare;41 more commonly, tuberculosis infection of the oral
mucosa arises secondary to pulmonary disease. Tubercu-
losis typically presents as solitary, necrotic ulcers of the
tongue. Infection by atypical mycobacteria (e.g. Mycobac-
terium avium complex) is rare, but may affect the oral mu-
cosa or gingiva, usually in HIV-infected individuals.42
Yeast and Fungal infections
While Candida species, usually Candida albicans, are
the most common fungal infection of the mouth, these
rarely give rise to oral ulcers. Chronic mucocutaneous can-
didiasis (CMC) is one of the most common T-cell diseases,
but the exact underlying defect is unknown. The disease
usually starts in early childhood, but it may also start as
late as early adolescence. Affected children have persist-
ent oral thrush, napkin dermatitis, skin infections, dys-
trophic nails, alopecia, and thrush on the genital skin and
oral mucous membranes. Candida granulomas rarely oc-
cur. Although fungal infection is the most important fea-
ture of this disease, in rare cases, recurrent bacterial infec-
tions and viral infections such as herpes simplex, herpes
zoster and hepatitis can occur. This condition may occa-
sionally give rise to ulcers of the dorsum of tongue.43
Systemic mycoses can cause oral ulcers, typically in
immunosuppressed hosts. In HIV disease, Aspergillus
fumigatum may give rise to long-standing ulcers of the
gingiva44 or oral mucosa as may Histoplasma capsulatum.45
South America paracoccidiodomycosis (South American
Blastomycosis) may give rise to large areas of ulcers remi-
niscent of oral SCC, with this infection arising in both im-
munocompetent and immunosuppressed individuals.46,47
Idiopathic ulcers
Recurrent aphthous stomatitis
The most common non-infectious and non-traumatic
oral mucosal ulcerative disorder is recurrent aphthous sto-
matitis (RAS) (Fig. 9). The disease affects non-keratinized
oral mucosa, especially the vestibulum, soft palate, tongue
and sublingual area. It is clinically characterized by recur-
rent episodes of oral ulceration in an otherwise healthy in-
dividual. The ulcers arise every 4–12 weeks and may be
classified as minor, major, or herpetiform. The ulcers are
superficial, rounded and have a yellow-colored slough with
surrounding erythema. The ulcers of major RAS may cause
scarring upon healing, and it has been suggested that ul-
cers of herpetiform RAS may coalesce to produce large ar-
eas of ulcers that heal with scarring. Rarely, major aph-
Figure 9 - Recurrent aphthous stomatitis affecting non-keratinised oral
mucosa
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thous stomatitis causes tissue destruction (e.g. of the soft
palate).
Undoubtedly, RAS has an immunologically mediated
pathogenesis; however, the precise cause of RAS remains
unclear. Reduced percentages of CD4 and CD8 cells in pe-
ripheral blood have been documented, but the results are
still controversial.48 Suggested etiologies include idiopathic
hematoma deficiency, cessation of tobacco smoking, and
psychological stress, but there is little scientific evidence
to support of any of these. While superficial ulcers similar
to RAS may arise in gluten-sensitive enteropathy,49 the vast
majority of patients with RAS have no clinical,
gastroenterological, or serological features of this small
bowel disorder. To date, no common viral or bacterial in-
fection of the mouth has been implicated in the etiology
of RAS.48 There is also no consistent association between
Helicobacter pylori infection and RAS.50
Therapy for RAS is directed towards reducing the du-
ration and/or frequency of episodes of ulceration.51 Topi-
cal corticosteroids are used in the most cases; however, few
of these have been found to be significantly effective in
appropriate clinical studies. Chlorhexidine gluconate mouth
rinse may be of some benefit (and has been evaluated in
detail),52 but it has only limited clinical value in the man-
agement of RAS. Benzydamine hydrochloride spray or
mouth rinse provides some symptomatic relief, but does not
hasten ulcer healing. Although effective, systemic therapy
with prednisone is rarely warranted, and the mechanism of
this effect is unclear.53-55 Thalidomide is highly effective,
but in view of the adverse side effects including
teratogenicity and neurotoxicity, its routine application for
such a recurrent and minor disorder is contraindicated.56
Ulcers similar to RAS are one of the cardinal features
of Behcet’s disease. The ulcers have only rarely been de-
scribed in detail, but seem to have the same clinical fea-
tures as RAS. A detailed discussion of Behcet’s disease can
be found elsewhere.57 Other disorders that can give rise to
RAS-like ulcers include a variant of Behcet’s disease
termed MAGIC syndrome, Sweet’s syndrome, and HIV dis-
ease.58 A rare disorder in childhood that is characterized
by pyrexia, pharyngitis, cervical lymphadenopathy and aph-
thous-like ulcers, sometimes termed PFAPA (periodic fe-
ver, aphthae, pharyngitis and adenitis), has also been de-
scribed.59
Oral ulcers related to systemic disease
Gastrointestinal disease
Gluten-sensitive enteropathy
Superficial oral mucosal ulcers similar to RAS may be
a feature of 1–5% patients with undiagnosed, untreated glu-
ten-sensitive enteropathy.60 The ulceration is presumably
due to the associated hematinic deficiencies.
Dermatitis herpetiformis and related disorders
Oral lesions in dermatitis herpetiformis have been de-
scribed only rarely. These may comprise oral mucosal vesi-
cles, blood-filled blisters, irregular ulcers and desquama-
tive gingitivitis. Linear IgA disease may likewise give rise
to blood-filled vesicles or bullae, irregular ulcers and desq-
uamative gingivitis. A long-term gluten-free diet (GFD) has
been used successfully as a first-choice treatment for der-
matitis herpetiformis (DH).61
Crohn’s disease and related disorders
Oral ulcers arise in approximately 9% of patients with
undiagnosed Crohn’s disease and can be the first and/or
only clinical features of this disorder. Crohn’s disease is a
systemic chronic inflammatory disorder that may involve
any part of the gastrointestinal tract, including the oral cav-
ity. The prevalence rates of oral manifestations vary be-
tween 5 and 20 per cent; however, in pediatric patients, the
prevalence is much higher (48% to 80%).62 Two types of
oral ulcers can arise in orofacial granulomatosis (OFG) and
Crohn’s disease – chronic deep linear ulcers, usually of the
buccal vestibules, which often have a rolled edge because
of mucosal tags; and superficial oral mucosal ulcers (Fig.
10) presumably resulting from hematinic deficiency. The
diagnosis of such ulcers requires establishing the presence
of non-caseating granulomas and the exclusion of other
granulomatous diseases, such as sarcoidosis.
The precise relationship between OFG and
gastrointestinal Crohn’s disease remains unclear since there
are few studies examining the gastrointestinal tract of chil-
Figure 10 - Superficial and irregular oral ulceration of tongue in OFG
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dren and adults with OFG. Certainly, there are reports of
OFG as an initial presentation of Crohn’s disease.63,64 Simi-
larly, OFG-like disease may be a feature of patients with
concurrent gastrointestinal Crohn’s disease.65,66 The human
leukocyte antigen (HLA) haplotype of patients with OFG
differs from that of Crohn’s disease.67 The precise associa-
tion between OFG and gastrointestinal Crohn’s disease re-
mains unknown.
Ulcerative colitis
Ulcerative colitis can give rise to either aphthous ul-
cers or to multiple pustules called pyostomatitis vegetans.
The ulcers of the latter arise on the upper and lower ante-
rior vestibules, the soft palate, and the posterior hard pal-
ate. Pyostomatitis vegetans tends to arise in patients with
undiagnosed or active ulcerative colitis. Although most fre-
quently associated with ulcerative colitis, pyostomatitis
vegetans may occasionally arise in Crohn’s disease.68 Pyo-
derma gangrenosum, manifesting as a solitary, necrotic
mucosal ulcer has also been reported in the mouth in rare
cases.69
Others
As discussed above, necrotizing sialometaplasia may
arise secondary to palatal trauma in bulimia nervosa.
Gastro-esophageal reflux does not cause oral ulceration,
although it has been associated with erosion of the palatal
aspects of the upper teeth.70
Lichen planus
Lichen planus is by far the most common dermatologi-
cal disorder that gives rise to oral ulcers. Lichen planus is
an immunologically mediated disorder that is histopatho-
logically characterized by an intense dermal infiltrate of
T-lymphocytes. The precise trigger for this immunologi-
cal reaction is unclear. There is no evidence that the clini-
cal features of idiopathic oral lichen planus are any differ-
ent from those of the drug-associated diseases (Figs. 11 and
12).71
Similarly, although histopathological differences be-
tween idiopathic lichen planus and drug-related diseases
have been described, there is profound inconsistency among
the proposed pathological hallmarks of these two disor-
ders.72 Drugs that may commonly give rise to lichen pla-
nus-like disease include sulphonyureas, non-steroidal anti-
inflammatory drugs, β-blockers, antimalarials, penicilla-
mine and gold. Associations between hepatitis C virus and
oral lichen planus probably reflect the epidemiology of
hepatitis C virus infection and/or use of interferon-α.73 A
lichen planus-like disorder can also arise in chronic graft-
versus-host disease.
Lichen planus only warrants treatment in patients who
are having painful symptoms and/or signs of erosion, ul-
cers, or blister formation. Typical treatment involves topi-
cal corticosteroids,74 although severe cases may warrant lo-
cal (e.g. topical tacrolimus) and systemic immunosuppres-
sant therapy75, 76, the latter of which does not have a strong
evidence base.
Of note, it has been suggested that oral lichen planus
may be potentially malignant. The evidence for this is gen-
erally based upon retrospective studies of large numbers
of affected patients. It is suggested that approximately 1–
3% of patients with long-standing lichen planus may de-
velop oral SCC.77 Often, however, the descriptions have not
detailed whether the tumor arose within existing lichen pla-
Figure 12 - Lateral view of erosive non-striated oral lichen planus affecting
the dorsum of the tongue
Figure 11 - Erosive non-striated oral lichen planus affecting the dorsum of
the tongue
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nus, and no detailed prospective control studies of the de-
velopment of oral SCC in long-standing lichen planus have
ever been undertaken.
Malignancy
The common malignancies of the mouth may manifest
as oral ulcers. SCC is the most common tumor of the
mouth, typically manifesting as a solitary ulcer of the dor-
sum of tongue or floor of mouth (Fig. 13). The ulceration
is locally destructive and, when affecting the tongue, may
give rise to lingual and/or hypoglossal nerve damage with
or without dysarthria or dysphagia. Gingival SCC may give
rise to tooth mobility and, very rarely, to a pathological
fracture of the mandible.
Oral SCC remains one of the more common cancers
worldwide, particularly in developing countries such as In-
dia.78-80 There is a rising frequency of oral SCC in the mid-
dle-aged adult population in the developed world. High to-
bacco (in any form) and alcohol consumption are the prin-
cipal etiological factors of oral SCC. Other suggestive
etiologies include human papilloma virus, malnourishment
(in particular deficiencies of vitamins A and C), and pos-
sibly poor oral hygiene.
Non-Hodgkin’s lymphoma
Non-Hodgkin’s lymphoma may manifest as a solitary
area of necrotic ulcers typically affecting the gingiva, pal-
ate and fauces. This tumor may arise de novo, but is often
associated with iatrogenic immunosuppression in HIV dis-
ease. A detailed review of non-Hodgkin’s lymphoma of the
mouth can be found elsewhere.81 NK/T-cell lymphoma
tends to affect the upper anterior gingival and palate; this
is a T-cell lymphoma, which is in contrast to most non-
Hodgkin’s lymphoma of the mouth.82,83
Drug therapy
A wide range of drugs can give rise to ulcers of the oral
mucosa.84 The mechanisms by which drugs cause oral ul-
cers include drug-induced neutropenia and anemia (e.g.
cytotoxics), lichenoid disease (e.g. sulphanylureas, â-
blockers, gold, penicillamine), pemphigus (e.g. angiotensin-
converting enzyme inhibitors), lupus, and IgA dermatoses.
Leishmaniasis
Cutaneous leishmaniasis, endemic in some parts of the
Americas, is caused by Leishmania viannia and Leishma-
nia mexicana species complexes. Infection with L. viannia
species, particularly Leishmania viannia braziliensis, results
in skin lesions that tend to be persistent and may be further
complicated by mucocutaneous involvement. Mucosal
leishmaniasis probably results from early hematogenous or
lymphatic spread from cutaneous lesions. It causes destruc-
tion of the facial structure, which may lead to aspiration,
infection, and even death. Mucosal leishmaniasis may ap-
pear at any time, from the first months after infection to dec-
ades afterward. Risk factors include large or multiple cu-
taneous lesions, male gender, and long-standing skin lesions
for which adequate systemic treatment has not been admin-
istered.85
Figure 13 - Oral squamous cell carcinoma on the dorsum of the tongue and
floor of the mouth.
RESUMO
Leão JC, Gomes VB, Porter S. Lesões ulcerativas da boca:
atualização para o clínico geral. Clinics. 2007;62(6):769-
80.
A ulceração oral é uma queixa comum dos pacientes que
são atendidos em ambulatórios. Com freqüência é difícil
estabelecer um diagnóstico preciso e atingir o controle dos
sinais e sintomas dos pacientes que apresentam ulceração
oral. Os pacientes acometidos por ulceração oral são
eventualmente encaminhados para os ambulatórios de
gastroenterologia, entretanto, a maioria das úlceras não
reflete doença gastrointestinal, e sim desordens sistêmicas
que podem se apresentar com sinais e sintomas clínicos
similares. O objetivo do presente artigo foi revisar aspectos
777
CLINICS 2007;62(6):769-80 Ulcerative lesions of the mouth
Leão JC et al.
da etiologia, diagnóstico e tratamento das desordens
ulcerativas mais comuns da mucosa oral. Foi realizada uma
busca no banco de dados MEDLINE da National Library
of Medicine. A seleção dos artigos, coleta de dados e
julgamento em termos da pertinência de inclusão foram
realizadas pelos autores. Baseado na literatura pesquisada,
foi concluído que existem várias doenças sistêmicas que
podem apresentar sinais e sintomas clínicos semelhantes e
o conhecimento de cada doença poderá guiar o clínico para
uma intervenção apropriada.
UNITERMOS: Ulceração Oral. Medicina Oral. Lesões
Orais. Estomatite Aftosa Recorrente. Ulceração Oral
Recorrente
REFERENCES
1. Gandara-Rey JM, Diniz-Freitas M, Gandara-Vila P, Blanco-Carrion A,
Garcia-Garcia A. Lesions of the oral mucosa in cocaine users who apply
the drug topically. Med Oral. 2002;7(2): 03-7.
2. Blanksma CJ, Brand HS. Cocaine abuse: orofacial manifestations and
implications for dental treatment. Int Dent J. 2005;55:365-9.
3. Goodger NM, Wang J, Pogrel MA. Palatal and nasal necrosis resulting
from cocaine misure. Br Dent J. 2005;198:333-4.
4. Epstein JB, Klasser GD. Emerging approaches for prophylaxis and
management of oropharyngeal mucositis in cancer therapy. Expert Opin
Emerg Drugs. 2006;11:353-73.
5. Dorr W, Reichel S, Spekl K. Effects of Keratinocyte growth factor
(palifermin) administration protocols on oral mucositis (mouse) induced
by fractionated irradiation. Radiother Oncol. 2005;75:99-105.
6. Fleisher G, Dorr W. Amelioration of early radiation effects in oral mucosa
(mouse) by intravenous or subcutaneous administration of amifostine.
Strahlenther Onkol. 2006;182:567-75.
7. Kelly C, Lindahl S, Malmberg L, Reizenstein J, Alenius M, Lewensohn
R. Therapeutic efficacy by recombinant human granulocyte monocyte-
colony stimulating factor on mucositis occuring in patients with oral
and oropharynx tumors treated with curative radiotherapy: a multicenter
open randomized phase III study. Med Oncol. 2005;22:247-56.
778
CLINICS 2007;62(6):769-80Ulcerative lesions of the mouth
Leão JC et al.
8. Robinson JA, Shankaramma Sc, Jetter P, Kienze U, Schwendener RA,
Vrijbloed JW, Obrecht D. Properties and structure-activity studies of
cyclic beta-hairpin peptidomimetics based on the cationic antimicrobial
peptide protegrin I. Bioorg Med Chem. 2005;13:2055-64.
9. Kominek P, Blasch P. Necrotizing sialometaplasia: a potential diagnostic
pitfall. Ear Nose Throat J. 2006;85:604-5.
10. Solomon LW, Merzianu M, Sullivan M, Rigual NR. Necrotizing
sialometaplasia associated with bulimia: case report and literature review.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:39-42.
11. Bunzli D, Wietlisbach V, Barazzoni F, Sahki R, Meylan PR.
Soroepidemiology of herpes simplex virus type 1 and 2 in Western and
Southern Switzerland in adults aged 25-74 in 1992-93: a population-
based study. BMC Infect Dis. 2004;174:10.
12. Malkin JE. Epidemiology of genital herpes simplex virus infection in
developed countries. Herpes. 2004;11 suppl 1:2A–23A.
13. Ficarra G. Oral ulcers in HIV-infected patients: an update on
epidemiology and diagnosis. Oral Dis. 1997;3 suppl 1:S183-9.
14. Kleymann G. Agents and strategies in development for improved
management of herpes simplex virus infection and disease. Expert Opin
Investig Drugs. 2005;14:135-61.
15. Wu JJ, Pang KR, Huang DB, Tyring SK. Advances in antiviral therapy.
Dermatol Clin. 2005;23:313-22.
16. Van der Pijl JW. Prevention of genital ulcerations during treatment with
foscarnet. Presse Med. 1992;21:395.
17. Morrel EM, Spruance SL, Goldberg DI and Iontophoretic Acyclovir
Cold Sore Study Group. Topical iontophoretic administration of
acyclovir for the episodic treatment of herpes labialis: a ramdomized,
double-blind, placebo-controlled, clinic-initiated trial. Clin Infect Dis.
2006;43:460-7.
18. Sarisky RT, Bacon T, Boon R, Locke L, Nguyen TT, Leary J, et al.
Penciclovir susceptibilities of herpes simplex virus isolates from patients
using penciclovir cream for treatment of recurrent herpes labialis.
Antimicrob Agents Chemother. 2002;46:2848–53.
19. Kokuba H, Imafuku S, Huang S, Aurelian L, Burnett JW. Erythema
multiforme lesions are associated with expression of a herpes simplex
virus (HSV) gene and qualitative alterations in the HSV-specific T-cell
response. Br J Dermatol. 1998;138:952–64.
20. Szczepanski T, De Vaan GA, Beishuizen A, Bogman J, Jansen MW, van
Wering ER et al. Acute lymphoblastic leukemia followed by a clonally-
unrelated EBV-positive non-Hodgkin lymphoma and a clonally-related
myelomonocytic leukemia cutis. Pediatr Blood Cancer. 2004;42:343–9.
21. Fluckiger R, Laifer G, Itin P, Meyer B, Lang C. Oral hairy leukoplakia
in a patient with ulcerative colitis. Gastroenterology. 1994;106:506–8.
22. Firth NA, Rich AM, Reade PC. Oral mucosal ulceration due to
cytomegalovirus associated with human immunodeficiency virus
infection. Case report and brief review. Aust Dent J. 1994;39:273-5.
23. Flaitz CM, Nichols CM, Hicks MJ. Herpesviridae-associated persistent
mucocutaneous ulcers in acquired immunodeficiency syndrome. A
clinicopathologic study. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod. 1996;81:433-41.
24. Lager I, Altini M, Coleman H, Ali H. Oral Kaposi’s sarcoma: a
clinicopathologic study from South Africa. Oral Surg Oral Med Oral
Pathol Oral Radiol Endod. 2003;96:701-10.
25. Reichart PA, Schiodt M. Non-pigmented oral Kaposi’s sarcoma (AIDS).
Report of two cases. Int J Oral Maxillofac Surg. 1989;18:197-9.
26. Diz DP, Ocampo HA, Miralles AC, Vazquez GE, Martinez VC.
Regression of AIDS-related Kaposi’s sarcoma following ritonavir
therapy. Oral Oncol. 1998;34:236-8.
27. Le Bourgeois JP, Frikha H, Piedbois P, Le Pechoux C, Martin L, Haddad
E. Radiotherapy in the management of epidemic Kaposi’s sarcoma of
the oral cavity, the eyelid and the genitals. Radiother Oncol.
1994;30:263-6.
28. Ramirez-Amador V, Esquivel-Pedraza L, Lozada-Nur F, et al.
Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the
treatment of oral Kaposi’s sarcoma. A double blind, randomized clinical
trial. Oral Oncol. 2002;38:460-7.
29. Scully C, Laskaris G, Pindborg J, Porter SR, Reichart P. Oral
manifestations of HIV infection and their management: II. Less common
lesions. Oral Surg Oral Med Oral Pathol. 1991;71:167-71.
30. Scully C, Laskaris G, Pindborg J, Porter SR, Reichart P. Oral
manifestations of HIV infection and their management: I. More common
lesions. Oral Surg Oral Med Oral Pathol. 1991;71:158-66.
31. MacPhail LA, Greenspan JS. Oral ulceration in HIV infection:
investigation and pathogenesis. Oral Dis. 1997;3:190-3.
32. Di Alberti L, Porter SR, Speight PM, Scully CM, Zakrzewska JM,
Williams IG et al. Detection of human herpesvirus-8 DNA in oral ulcer
tissues of HIV-infected individuals. Oral Dis. 1997;1:133-4.
33. Ramirez-Amador VA, Esquivel-Pedraza L, Ponce-de-Leon S, Reyes-
Teran G, Gonzalez-Guevara M, Ponce-de-Leon S et al. Thalidomide as
therapy for human immunodeficiency virus-related oral ulcers: a double-
blind placebo-controlled clinical trial. Clin Infect Dis. 1999;28:892-4.
34. Baccaglini L, Atkinson JC, Patton LL, Glick M, Ficarra G, Peterson
DE. Managment of oral lesions in HIV-positive patients. Oral Surg Oral
Med Oral Pathol Oral Radiol Endod. 2007;103:21-23.
35. Okolo S, Chukwu G, Eqbuonu I, Ezeogu F, Onwuanaku C, Adeleke O
et al. Oral hygiene and nutritional status of children aged 1-7 years in a
rural community. Ghana Med J. 2006;40: 22-5.
36. Enwonwu CO, Falkler WA Jr, Idigbe EO, Afolabi BM, Ibrahim M,
Onwujekwe D et al. Pathogenesis of cancrum oris (noma): confounding
interactions of malnutrition with infection. Am J Trop Med Hyg.
1999;60:223-32.
37. Jones AC, Gulley ML, Freedman PD. Necrotizing ulcerative stomatitis
in human immunodeficiency virus-seropositive individuals: a review
of the histopathologic, immunohistochemical, and virologic
characteristics of 18 cases. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod. 2000;89:323-32.
38. Adekeye EO, Ord RA. Cancrum oris: principles of management and
reconstructive surgery. J Maxillofac Surg. 1983;11:160-70.
39. Alam F, Argiriadou AS, Hodgson TA, Kumar N, Porter SR. Primary
syphilis remains a cause of oral ulceration. Br Dent J. 2000;189:352–4.
40. Steiner M, Alexander WN. Primary syphilis of the gingiva. Report of
two cases. Oral Surg Oral Med Oral Pathol. 1966;21:530–5.
41. Schofer H. Syphilis. Clinical aspects of Treponema pallidum infection.
Hautarzt. 2004;55:112-9.
779
CLINICS 2007;62(6):769-80 Ulcerative lesions of the mouth
Leão JC et al.
42. Ajay GN, Laxmikanth C, Prashanth SK. Tuberculous ulcer of tongue
with oral complications of oral antituberculosis therapy. Indian J Dent
Res. 2006;17:87-90.
43. Ilyas SE, Chen FF, Hodgson TA, Speight PM, Lacey CJ, Porter SR.
Labial tuberculosis: a unique cause of lip swelling complicating HIV
infection. HIV Med. 2002;3:283-6.
44. Sathis Kumar T, Xavier SJ, Renu G. Chronic mucocutaneous candidiasis
in a child. Indian J Dermatol Venerol Leprol. 2005;71:432-3.
45. Myoken Y, Sugata T, Kyo TI, Fujihara M. Pathological features of
invasive oral aspergillosis in patients with hematologic malignancies. J
Oral Maxillofac Surg. 1996;54:263-70.
46. Loh FC, Yeo JF, Tan WC, Kumarasinghe G. Histoplasmosis presenting
as hyperplastic gingival lesion. J Oral Pathol Med. 1989;18:533–6.
47. Scully C, de Almeida OP. Orofacial manifestations of the systemic
mycoses. J Oral Pathol Med. 1992;21:289-94.
48. Ranganathan K, Hemalatha R. Oral lesions in HIV infection in
developing countries: an overview. Adv Dent Res. 2006;19:63-8.
49. Moraru RA, Grossman ME. Palatal necrosis in an AIDS patient: a case
of mucormycosis. Cutis. 2000;66:15-8.
50. Porter SR, Scully C, Pedersen A. Recurrent aphthous stomatitis. Crit
Rev Oral Biol Med. 1998;9:306-21.
51. Srinivasan U, Weir DG, Feighery C, O’Farrelly C. Emergence of classic
enteropathy after longstanding gluten sensitive oral ulceration. BMJ.
1998;316:206-7.
52. Porter SR, Barker GR, Scully C, Macfarlane G, Bain L. Serum IgG
antibodies to Helicobacter pylori in patients with recurrent aphthous
stomatitis and other oral disorders. Oral Surg Oral Med Oral Pathol
Oral Radiol Endod. 1997;83:325-8.
53. Porter S, Scully C. Aphthous ulcers: recurrent. Clin Evid. 2002;8:1397-
403.
54. Hunter L, Addy M. Chlorhexidine gluconate mouthwash in the
management of minor aphthous ulceration. A double-blind, placebo-
controlled cross-over trial. Br Dent J. 1987;162:106-10.
55. Barrons RW. Treatment strategies for recurrent oral aphthous ulcers.
Am J Health Syst Pharm. 2001;58:41-50.
56. MacPhail L. Topical and systemic therapy for recurrent aphthous
stomatitis. Semin Cutan Med Surg. 1997;16:301-7.
57. Eisen D, Lynch DP. Selecting topical and systemic agents for recurrent
aphthous stomatitis. Cutis. 2001;68:201-6.
58. Shetty K. Thalidomide in the management of recurrent aphthous
ulcerations in patients who are HIV-positive: a review and case reports.
Spec Care Dentist. 2005;25:236-41.
59. Arayssi T, Hamdan A. New insights into the pathogenesis and therapy
of Behcet’s disease. Curr Opin Pharmacol. 2004;4:183-8.
60. Femiano F, Gombos F, Scully C. Sweet’s syndrome: recurrent oral
ulceration, pyrexia, thrombophlebitis, and cutaneous lesions. Oral Surg
Oral Med Oral Pathol Oral Radiol Endod. 2003;95:324-7.
61. Feder HM Jr. Periodic fever, aphthous stomatitis, pharyngitis, adenitis:
a clinical review of a new syndrome.Curr Opin Pediatr. 2000;12:253-6.
62. Nowak M, Dziechciarz P, Dwilewicz-Trojaczek J. The frequency of
coeliac disease occurrence in patients with recurrent aphthous stomatitis
(RAS) – preliminary report. Wiad Lek. 2002;55:542-6.
63. O’Regan E, Bane A, Flint S, Timon C, Toner M. Linear IgA disease
presenting as desquamative gingivitis: a pattern poorly recognized in
medicine. Arch Otolaryngol Head Neck Surg. 2004;130:469-72.
64. Harty S, Fleming P, Rowland M, Crushell E, McDermott M, Drumm B,
et al. A prospective study of the oral manifestations of Crohn’s disease.
Clin Gastroenterol Hepatol. 2005;3:886-91.
65. Sanderson J, Nunes C, Escudier M, Barnard K. Oro-facial
granulomatosis: Crohn’s disease or a new inflamatory bowel disease?
Inflamm Bowel Dis. 2005;11:840-6.
66. Kauzman A, Quesnel-Mercier A, Lalonde B. Orofacial granulomatosis:
2 cases reports and literature review. J Can Dent Assoc. 2006;71:325-9.
67. Orosz M, Sonkodi I. Oral manifestations in Crohn’s disease and dental
management. Fogorv Sz. 2004;97:113-7.
68. Tyldesley WR. Oral Crohn’s disease and related conditions. Br J Oral
Surg. 1979;17:1-9.
69. Gibson J, Neilly JB, Wray AP, Evans TJ, MacKenzie JR, McKillop JH.
[99Tcm]-HMPAO leucocyte labelling in orofacial granulomatosis and
gastrointestinal Crohn’s disease in childhood and early adulthood. Nucl
Med Commun. 2000;21:155-8.
70. Ficarra G, Cicchi P, Amorosi A, Piluso S. Oral Crohn’s disease and
pyostomatitis vegetans. An unusual association. Oral Surg Oral Med
Oral Pathol. 1993;75:220-4.
71. Hernandez-Martin A, Arias-Palomo D, Hermida G, Gutiérrez-Ortega
MC, Ramírez-Herrera M, Rodríguez-Vegas M et al. Oral pyoderma
gangrenosum. Br J Dermatol. 2003;149:663-4.
72. Lackey MA, Barth J. Gastroesophageal reflux disease: a dental concern.
Gen Dent. 2003;51:250-4.
73. Scully C, Beyli M, Ferreiro MC, Ficarra G, Gill Y, Griffiths M et al.
Update on oral lichen planus: etiopathogenesis and management. Crit
Rev Oral Biol Med. 1998;9:86-122.
74. McCartan BE, McCreary CE. Oral lichenoid drug eruptions. Oral Dis.
1997;3: 58-63.
75. Bratel J, Dahlgren U, Simark MC, Jontell M. The frequency of different
T-cell receptor V-families in oral lichen planus and lichenoid contact
lesions: an immunohistochemical study. J Oral Pathol Med.
1998;27:415-9.
76. Nagao Y, Sata M, Ide T. Development and exacerbation of oral lichen
planus during and after interferon therapy for hepatitis C. Eur J Clin
Invest. 1996;26:1171-4.
77. Hegarty AM, Hodgson TA, Lewsey JD, Porter SR. Fluticasone
propionate spray and betamethasone sodium phosphate mouthrinse: a
randomized crossover study for the treatment of symptomatic oral lichen
planus. J Am Acad Dermatol. 2002;47:271-9.
78. Kaliakatsou F, Hodgson TA, Lewsey JD, Hegarty AM, Murphy AG,
Porter SR. Management of recalcitrant ulcerative oral lichen planus with
topical tacrolimus. J Am Acad Dermatol. 2002;46:35-41.
79. Porter SR, Scully C, Eveson JW. The efficacy of topical cyclosporin in
the management of desquamative gingivitis due to lichen planus. Br J
Dermatol. 1993;129:753-5.
780
CLINICS 2007;62(6):769-80Ulcerative lesions of the mouth
Leão JC et al.
80. Rodstrom PO, Jontell M, Mattsson U, Holmberg E. Cancer and oral
lichen planus in a Swedish population. Oral Oncol. 2004;40:131-8.
81. Silverman S, Bhargava K, Smith LW, Malaowalla AM. Malignant
transformation and natural history of oral leukoplakia in 57,518
industrial workers of Gujarat, India. Cancer. 1976;38:1790-5.
82. Gupta PC, Mehta FS, Pindborg JJ. Intervention study for primary
prevention of oral cancer among 36000 Indian tobacco users. Lancet.
1986;1:1235-9.
83. Rajkumar T, Sridhar H, Balaram P. Oral cancer in Southern India: the
influence of body size, diet, infections and sexual practices. Eur J Cancer
Prev. 2003;12:135-43.
84. Porter S, Scully C. HIV: the surgeon’s perspective: Part 3. Diagnosis
and management of malignant neoplasms. Br J Oral Maxillofac Surg.
1994;32:241-7.
85. Scope A, Trau H, Bakon M, Yarom N, Nasereddin A, Schwartz E.
Imported mucosal leishmaniasis in a traveler. Clin Infect Dis.
2003;37:83-7.
